Third-Line Therapy For Gist

Third-Line Therapy for GIST

Targeted Oncology

GIST: Third-Line Treatment Considerations

Targeted Oncology

Third-Line Therapy for Metastatic GIST

Targeted Oncology

Toxicity Management for GIST Third-Line Therapy

Targeted Oncology

Progressing Gastrointestinal Stromal Tumor

Targeted Oncology

Utilizing Newer TKIs to Treat GIST

Targeted Oncology

Diagnosis of Metastatic GIST

Targeted Oncology

Imatinib Therapy for Resectable GIST

Targeted Oncology

Mastering GIST treatment: Imatinib and other targeted therapy for gastrointestinal stromal tumors

Edusurg Clinics

Standard Treatment Options for Metastatic GIST

Targeted Oncology

Dr. Keedy on Regorafenib for the Treatment of GIST

INVICTUS: long-term results for ripritnanib as 4th-line therapy in advanced GIST

INTRIGUE: ripretinib vs. sunitinib in patients with advanced GISTs

Gastrointestinal Stromal Tumor (GIST) of the Stomach

Hassan Aziz, MD

Therapeutic strategy in GIST tumors

Recent Updates on the Mutational and Treatment Landscape of Advanced GIST

Side Effects Associated With Other Treatments for GIST

Treatment Options in Gastrointestinal Stromal Tumors

Targeted Oncology

Tyrosine Kinase Inhibition in Gastrointestinal Stromal Tumors

Third-Line Treatment in Refractory CRC